Construction of the "Patient-Centered"Molecular Pathology Diagnostic Center
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01311388|
Recruitment Status : Unknown
Verified March 2011 by Taipei Medical University WanFang Hospital.
Recruitment status was: Active, not recruiting
First Posted : March 9, 2011
Last Update Posted : March 9, 2011
|Condition or disease|
This research is going to discuss the biomarker expression of common malignant neoplasm (tumor)among Taiwanese, such as large intestine rectal cancer, breast cancer, prostate gland cancer, lung cancer, oral cancer, gastric cancer, liver cancer, cervical cancer, cancer of the womb, ovarian cancer, carcinoma of urinary bladder, kidney cancer and so on.
The investigators hope to find the biomarker of common tumors among Taiwanese in order to develop the tools of tumor screening, diagnosis, treatment methods and prediction prognosis
|Study Type :||Observational|
|Estimated Enrollment :||1500 participants|
|Official Title:||Construction of the "Patient-Centered"Molecular Pathology Diagnostic Center|
|Study Start Date :||August 2010|
|Estimated Study Completion Date :||December 2013|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01311388
|Principal Investigator:||Wen-Ta Chiu||TMU-CECR|